Neuland Labs Q2 FY26: Revenue up 65% YoY at Rs 514 crore, PAT jumps to Rs 97 crore

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.5%Reaction day

₹17767.00

prior close

₹19000.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.0%+1.5% vs market

Pharmaceuticals peers, median of 155sector-0.1%+1.6% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty Smallcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.9

10m

+0.4

15m

-1.1

30m

-2.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.5-0.0+1.5-0.1+1.6

Next day

-3.5-0.2-3.3-0.7-2.8

-1.3+0.6-1.9+0.4-1.7

-3.0+0.2-3.2+0.0-3.0

-2.1+0.4-2.4+0.4-2.4

-2.3+1.0-3.3+0.3-2.6

-4.1-0.4-3.7-0.7-3.4

15d

-6.8-1.5-5.4-1.4-5.4

-8.2-5.0-3.2-3.6-4.6

-17.7-5.4-12.3-6.2-11.5

-24.3-3.9-20.4-6.7-17.6

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Neuland Labs reported strong Q2 FY26 results with consolidated revenue from operations at Rs 514.27 crore, up 65% from Rs 310.84 crore YoY. Q2 PAT surged to Rs 96.85 crore from Rs 32.84 crore. H1 FY26 revenue was Rs 807 crore vs Rs 750 crore, with PAT at Rs 110.75 crore vs Rs 130.71 crore (lower YoY due to a one-time property sale gain in H1 FY25). EBITDA margin expanded sharply to around 30.6% in Q2 from 21.4% YoY, reflecting operating leverage. Auditors issued an unmodified review opinion.

Likely market impact

Strong Q2 print with sharp margin expansion and 65% topline growth should boost sentiment. H1 PAT dip is technical, caused by a base effect from an exceptional property gain.